KPTI Competitors & Alternatives

Compare Karyopharm Therapeutics Inc with similar stocks in the same industry

Biotechnology

KPTI

Main Stock
$10.05
Tradestie Score
59
Market Cap
$53.85M
Revenue Growth
0.2%
Analyst Upside
+34.3%

Top Competitors

234 stocks in Biotechnology
Company Price Market Cap P/E Score Action
DBVT DBV Technologies S.A.
$15.98
$275.54M - 57 Compare
ALLO Allogene Therapeutics, Inc. Common Stock
$1.93
$275.13M - 44 Compare
VOR Vor Biopharma Inc. Common Stock
$18.03
$269.08M - 59 Compare
KYTX Kyverna Therapeutics, Inc. Common Stock
$7.77
$258.18M - 46 Compare
VTYX Ventyx Biosciences, Inc. Common Stock
$14.00
$256.71M - 53 Compare
NGNE Neurogene, Inc. Common Stock
$38.32
$256.54M - 62 Compare
HRTX Heron Therapeutics, Inc.
$0.42
$229.14M - 43 Compare
SLS SELLAS Life Sciences Group, Inc. Common Stock
$12.62
$211.22M - 55 Compare
ACRS Aclaris Therapeutics, Inc.
$5.50
$202.58M - 63 Compare
ASMB Assembly Biosciences, Inc
$26.96
$188.81M 342.5 55 Compare

Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)

234 stocks in this industry